1. Home
  2. HOWL vs INVE Comparison

HOWL vs INVE Comparison

Compare HOWL & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • INVE
  • Stock Information
  • Founded
  • HOWL 2017
  • INVE 1990
  • Country
  • HOWL United States
  • INVE United States
  • Employees
  • HOWL N/A
  • INVE N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • INVE Computer peripheral equipment
  • Sector
  • HOWL Health Care
  • INVE Technology
  • Exchange
  • HOWL Nasdaq
  • INVE Nasdaq
  • Market Cap
  • HOWL 87.4M
  • INVE 86.5M
  • IPO Year
  • HOWL 2021
  • INVE 1997
  • Fundamental
  • Price
  • HOWL $1.36
  • INVE $3.51
  • Analyst Decision
  • HOWL Strong Buy
  • INVE Strong Buy
  • Analyst Count
  • HOWL 2
  • INVE 2
  • Target Price
  • HOWL $9.50
  • INVE $7.25
  • AVG Volume (30 Days)
  • HOWL 265.6K
  • INVE 39.3K
  • Earning Date
  • HOWL 03-06-2025
  • INVE 03-11-2025
  • Dividend Yield
  • HOWL N/A
  • INVE N/A
  • EPS Growth
  • HOWL N/A
  • INVE N/A
  • EPS
  • HOWL N/A
  • INVE 3.10
  • Revenue
  • HOWL $3,386,000.00
  • INVE $104,217,000.00
  • Revenue This Year
  • HOWL N/A
  • INVE N/A
  • Revenue Next Year
  • HOWL $34.17
  • INVE N/A
  • P/E Ratio
  • HOWL N/A
  • INVE $1.16
  • Revenue Growth
  • HOWL N/A
  • INVE 70.57
  • 52 Week Low
  • HOWL $1.26
  • INVE $2.95
  • 52 Week High
  • HOWL $8.19
  • INVE $9.24
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 41.40
  • INVE 43.25
  • Support Level
  • HOWL $1.26
  • INVE $3.50
  • Resistance Level
  • HOWL $1.45
  • INVE $3.82
  • Average True Range (ATR)
  • HOWL 0.09
  • INVE 0.18
  • MACD
  • HOWL 0.02
  • INVE -0.01
  • Stochastic Oscillator
  • HOWL 45.45
  • INVE 21.82

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

Share on Social Networks: